Impact of Psychiatric Illnesses and Selective Serotonin Reuptake Inhibitor Medications on Baseline Neurocognitive Testing.

Zerubabbel K AsfawTheodore C HannahMuhammad AliAdam Y LiZachary SpieraNaoum Fares MarayatiRoshini KalagaraNickolas DreherAlexander J SchupperAlex GometzMark R LovellTanvir Choudhri

Published in: Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists (2021)

Clinicians should consider the impact of HPI on baseline neurocognitive performance during the assessment of a suspected SRC. Additional research is required to bolster our findings on SSRI use and ascertain the effects of other drug classes on baseline neurocognitive performance.

Keyphrases

bipolar disorder
mental health
tyrosine kinase
palliative care
emergency department
adverse drug
electronic health record